Kawasaki, Japan

Megumu Higaki

This inventor holds 1 USPTO granted patent. Top assignee: Ltt Institute Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Megumu Higaki. Retrieved from https://idiyas.com/inventor/megumu-higaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Megumu Higaki: Innovator in Medicinal Technology

Introduction

Megumu Higaki is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicinal technology, particularly in the area of nasal administration of medicaments. His innovative approach aims to enhance disease prevention and treatment through advanced formulations.

Latest Patents

Higaki holds a patent for a unique medicament designed for nasal administration. This medicament comprises a vaccine or a pharmacologically active peptide compounded with an ion exchange resin or adsorbent resin powder. The mean particle size of the resin powder is not larger than 200 micrometers, which is crucial for effective delivery and absorption.

Career Highlights

Megumu Higaki is associated with LTT Institute Co., Ltd., where he continues to develop and refine his innovative ideas. His work focuses on improving the efficacy of medicinal products, particularly in the realm of vaccines and therapeutic peptides.

Collaborations

Throughout his career, Higaki has collaborated with esteemed colleagues such as Yutaka Mizushima and Yasuo Kosaka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medicinal technology.

Conclusion

Megumu Higaki's contributions to the field of medicinal technology, particularly through his patent for nasal administration medicaments, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…